EA201892229A1 - Замещенные аминопуриновые соединения, содержащие их композиции и способы лечения с их применением - Google Patents
Замещенные аминопуриновые соединения, содержащие их композиции и способы лечения с их применениемInfo
- Publication number
- EA201892229A1 EA201892229A1 EA201892229A EA201892229A EA201892229A1 EA 201892229 A1 EA201892229 A1 EA 201892229A1 EA 201892229 A EA201892229 A EA 201892229A EA 201892229 A EA201892229 A EA 201892229A EA 201892229 A1 EA201892229 A1 EA 201892229A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compositions
- aminopurin
- substituted
- application
- compounds containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
В настоящем документе предложены способы лечения или предупреждения рака, включая солидные опухоли и гематологические онкологические заболевания, включающие введение эффективного количества аминопуриновых соединений формулы (I), и композиции, содержащие эффективное количество таких соединений.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662317412P | 2016-04-01 | 2016-04-01 | |
PCT/US2017/025252 WO2017173206A1 (en) | 2016-04-01 | 2017-03-31 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201892229A1 true EA201892229A1 (ru) | 2019-03-29 |
EA039392B1 EA039392B1 (ru) | 2022-01-21 |
Family
ID=59959573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201892229A EA039392B1 (ru) | 2016-04-01 | 2017-03-31 | Способ лечения рака с применением замещенного аминопуринового соединения |
Country Status (15)
Country | Link |
---|---|
US (1) | US10576085B2 (ru) |
EP (1) | EP3436018A4 (ru) |
JP (1) | JP7014731B2 (ru) |
KR (1) | KR102356433B1 (ru) |
CN (1) | CN109069512B (ru) |
AU (1) | AU2017241837B2 (ru) |
BR (1) | BR112018070163A2 (ru) |
CA (1) | CA3018986A1 (ru) |
CL (1) | CL2018002787A1 (ru) |
EA (1) | EA039392B1 (ru) |
IL (1) | IL262007B2 (ru) |
MX (1) | MX2018011992A (ru) |
NZ (1) | NZ746554A (ru) |
SG (2) | SG10202009589UA (ru) |
WO (1) | WO2017173206A1 (ru) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201116559D0 (en) | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
US10202365B2 (en) | 2015-02-06 | 2019-02-12 | Blueprint Medicines Corporation | 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors |
JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JO3633B1 (ar) | 2015-09-16 | 2020-08-27 | Katholieke Univ Leuven Ku Leuven Research & Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JOP20160198B1 (ar) | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
TWI787018B (zh) | 2015-11-02 | 2022-12-11 | 美商纜圖藥品公司 | 轉染過程重排之抑制劑 |
MX2018011784A (es) | 2016-03-31 | 2019-02-13 | Janssen Pharmaceuticals Inc | Derivados de indol sustituidos como inhibidores de la replicacion virica del dengue. |
WO2017167953A1 (en) | 2016-03-31 | 2017-10-05 | Janssen Pharmaceuticals, Inc. | Substituted indoline derivatives as dengue viral replication inhibitors |
BR112018068956A2 (pt) | 2016-04-01 | 2019-01-22 | Janssen Pharmaceuticals Inc | derivados do composto indol substituídos como inibidores da replicação viral da dengue |
JP6995058B2 (ja) | 2016-04-01 | 2022-02-21 | シグナル ファーマシューティカルズ,エルエルシー | (1s,4s)-4-(2-(((3s,4r)-3-フルオロテトラヒドロ-2h-ピラン-4-イル)アミノ)-8-((2,4,6-トリクロロフェニル)アミノ)-9h-プリン-9-イル)-1-メチルクロロヘキサン-1-カルボキサミドの固体形態及びその使用方法 |
JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JOP20180026A1 (ar) | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
PE20200342A1 (es) | 2017-05-22 | 2020-02-14 | Janssen Pharmaceuticals Inc | Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue |
ES2929667T3 (es) | 2017-05-22 | 2022-11-30 | Janssen Pharmaceuticals Inc | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue |
KR20200062270A (ko) | 2017-10-04 | 2020-06-03 | 셀진 코포레이션 | 시스-4-[2-{[(3s,4r)-3-플루오로옥산-4-일]아미노}-8-(2,4,6-트리클로로아닐리노)-9h-퓨린-9-일]-1-메틸시클로헥산-1-카르복스아미드의 조성물 및 이용 방법 |
LT3773589T (lt) | 2018-04-03 | 2024-02-12 | Blueprint Medicines Corporation | Ret inhibitorius, skirtas naudoti vėžiui gydyti, esant ret pakitimui |
CN112703014A (zh) * | 2018-08-10 | 2021-04-23 | 缆图药品公司 | Egfr突变型癌症的治疗 |
KR20220016456A (ko) * | 2019-04-16 | 2022-02-09 | 비바체 테라퓨틱스, 인크. | 바이사이클릭 화합물 |
EP4061364A4 (en) * | 2019-11-20 | 2023-09-13 | Vivace Therapeutics, Inc. | HETEROARYL COMPOUNDS |
WO2022002118A1 (zh) * | 2020-07-01 | 2022-01-06 | 四川海思科制药有限公司 | 一种并环杂环衍生物及其在医药上的应用 |
CN114681456A (zh) * | 2022-02-23 | 2022-07-01 | 中山大学附属第六医院 | Plx3397在结直肠癌的治疗中的用途 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5391485A (en) | 1985-08-06 | 1995-02-21 | Immunex Corporation | DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues |
JPS63500636A (ja) | 1985-08-23 | 1988-03-10 | 麒麟麦酒株式会社 | 多分化能性顆粒球コロニー刺激因子をコードするdna |
US4810643A (en) | 1985-08-23 | 1989-03-07 | Kirin- Amgen Inc. | Production of pluripotent granulocyte colony-stimulating factor |
IL99699A (en) | 1990-10-10 | 2002-04-21 | Autoimmune Inc | Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes |
FI109088B (fi) | 1997-09-19 | 2002-05-31 | Leiras Oy | Tabletti ja menetelmä sen valmistamiseksi |
PT1699800E (pt) * | 2003-12-23 | 2010-04-12 | Novartis Ag | Inibidores de quinase p-38 heterocíclicos bicíclicos |
US7723340B2 (en) * | 2005-01-13 | 2010-05-25 | Signal Pharmaceuticals, Llc | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
US7759342B2 (en) * | 2005-01-13 | 2010-07-20 | Signal Pharmaceuticals, Llc | Methods of treatment and prevention using haloaryl substituted aminopurines |
US7521446B2 (en) | 2005-01-13 | 2009-04-21 | Signal Pharmaceuticals, Llc | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
US20070225304A1 (en) * | 2005-09-06 | 2007-09-27 | Pharmacopeia Drug Discovery, Inc. | Aminopurine derivatives for treating neurodegenerative diseases |
WO2007062338A2 (en) | 2005-11-18 | 2007-05-31 | Astrazeneca Ab | Solid formulations |
EP2038041A4 (en) * | 2006-05-12 | 2010-02-17 | Myriad Genetics Inc | THERAPEUTIC COMPOUNDS AND THEIR USE AGAINST CANCER |
TWI398252B (zh) | 2006-05-26 | 2013-06-11 | Novartis Ag | 吡咯并嘧啶化合物及其用途 |
NZ576347A (en) | 2006-10-27 | 2011-10-28 | Signal Pharm Llc | Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith |
EP2279731B1 (en) | 2008-04-23 | 2012-12-12 | Farmasierra Manufacturing, S.L. | Improved pharmaceutical composition containing ibuprofen and codeine |
WO2011071491A1 (en) | 2009-12-09 | 2011-06-16 | Signal Pharmaceuticals, Llc | Isotopologues of 4-[9-(tetrahydro-furan-3-yl)-8-(2, 4, 6- trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol |
US8603527B2 (en) | 2010-10-25 | 2013-12-10 | Signal Pharmaceuticals, Llc | Pharmaceutical formulations of a substituted diaminopurine |
US8680076B2 (en) | 2010-10-25 | 2014-03-25 | Signal Pharmaceuticals, Llc | Methods of treatment, improvement and prevention using haloaryl substituted aminopurines |
US9466042B2 (en) | 2012-01-24 | 2016-10-11 | International Business Machines Corporation | Facilitating the design of information technology solutions |
WO2014172616A2 (en) | 2013-04-18 | 2014-10-23 | President And Fellows Of Harvard College | Methods, compositions and kits for promoting motor neuron survival and treating and diagnosing neurodegenerative disorders |
GB201321737D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic Agents |
TW201629063A (zh) * | 2014-10-06 | 2016-08-16 | 標誌製藥公司 | 經取代胺基嘌呤化合物、其組合物及用其之治療方法 |
CN115131834A (zh) * | 2015-08-13 | 2022-09-30 | 小米科技有限责任公司 | 移动设备及其屏幕模组、指纹采集方法、装置及电子设备 |
JP6995058B2 (ja) * | 2016-04-01 | 2022-02-21 | シグナル ファーマシューティカルズ,エルエルシー | (1s,4s)-4-(2-(((3s,4r)-3-フルオロテトラヒドロ-2h-ピラン-4-イル)アミノ)-8-((2,4,6-トリクロロフェニル)アミノ)-9h-プリン-9-イル)-1-メチルクロロヘキサン-1-カルボキサミドの固体形態及びその使用方法 |
-
2017
- 2017-03-31 EA EA201892229A patent/EA039392B1/ru unknown
- 2017-03-31 JP JP2018551358A patent/JP7014731B2/ja active Active
- 2017-03-31 CN CN201780021651.0A patent/CN109069512B/zh active Active
- 2017-03-31 US US15/475,899 patent/US10576085B2/en active Active
- 2017-03-31 BR BR112018070163A patent/BR112018070163A2/pt not_active Application Discontinuation
- 2017-03-31 KR KR1020187028514A patent/KR102356433B1/ko active IP Right Grant
- 2017-03-31 IL IL262007A patent/IL262007B2/en unknown
- 2017-03-31 EP EP17776735.7A patent/EP3436018A4/en active Pending
- 2017-03-31 AU AU2017241837A patent/AU2017241837B2/en active Active
- 2017-03-31 CA CA3018986A patent/CA3018986A1/en not_active Abandoned
- 2017-03-31 SG SG10202009589UA patent/SG10202009589UA/en unknown
- 2017-03-31 NZ NZ746554A patent/NZ746554A/en unknown
- 2017-03-31 WO PCT/US2017/025252 patent/WO2017173206A1/en active Application Filing
- 2017-03-31 MX MX2018011992A patent/MX2018011992A/es unknown
- 2017-03-31 SG SG11201808388QA patent/SG11201808388QA/en unknown
-
2018
- 2018-09-28 CL CL2018002787A patent/CL2018002787A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EA039392B1 (ru) | 2022-01-21 |
WO2017173206A1 (en) | 2017-10-05 |
EP3436018A1 (en) | 2019-02-06 |
IL262007A (en) | 2018-10-31 |
SG10202009589UA (en) | 2020-10-29 |
AU2017241837A1 (en) | 2018-10-25 |
EP3436018A4 (en) | 2019-11-13 |
SG11201808388QA (en) | 2018-10-30 |
KR102356433B1 (ko) | 2022-01-27 |
BR112018070163A2 (pt) | 2019-01-29 |
CL2018002787A1 (es) | 2019-01-18 |
CA3018986A1 (en) | 2017-10-05 |
US10576085B2 (en) | 2020-03-03 |
MX2018011992A (es) | 2019-01-24 |
CN109069512A (zh) | 2018-12-21 |
AU2017241837B2 (en) | 2021-07-22 |
US20170281633A1 (en) | 2017-10-05 |
KR20180126497A (ko) | 2018-11-27 |
CN109069512B (zh) | 2022-06-14 |
NZ746554A (en) | 2023-03-31 |
JP7014731B2 (ja) | 2022-02-01 |
IL262007B (en) | 2022-12-01 |
IL262007B2 (en) | 2023-04-01 |
JP2019510066A (ja) | 2019-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201892229A1 (ru) | Замещенные аминопуриновые соединения, содержащие их композиции и способы лечения с их применением | |
EA202092590A1 (ru) | Пиридазиноны в качестве ингибиторов parp7 | |
EA201891494A1 (ru) | Гетероциклические соединения в качестве иммуномодуляторов | |
EA201890857A1 (ru) | Соединения, применимые в качестве иммуномодуляторов | |
EA201990221A1 (ru) | 1,3-дигидроксифенильные производные, применимые в качестве иммуномодуляторов | |
EA201891203A1 (ru) | Гетероциклические соединения в качестве иммуномодуляторов | |
EA201990495A1 (ru) | Биарильные соединения, применимые в качестве иммуномодуляторов | |
EA201891268A1 (ru) | Соединения, которые можно применять в качестве ингибиторов киназы | |
EA201990187A1 (ru) | Антипролиферационные средства на основе пиримидина | |
PH12020550901A1 (en) | Macrocyclic compounds for treating disease | |
EA201891200A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201791563A1 (ru) | Замещенные нуклеозидные производные, полезные в качестве агентов против рака | |
EA201790174A1 (ru) | Антипролиферативные соединения и способы их применения | |
EA201592024A1 (ru) | Замещенные 5-(3,5-диметилизоксазол-4-ил)-индолин-2-оны | |
EA201990296A1 (ru) | Антитела против siglec-7 для лечения рака | |
EA201691857A1 (ru) | Соединения, применимые в качестве иммуномодуляторов | |
EA201790779A1 (ru) | Замещенные аминопуриновые соединения, их композиции и способы лечения с использованием таких соединений | |
EA201890858A1 (ru) | 2,4-дигидроксиникотинамиды как агонисты apj | |
EA202090497A1 (ru) | Соединения и композиции для лечения гематологических нарушений | |
TN2018000119A1 (en) | Dihydroimidazopyrazinone derivatives useful in the treatment of cancer | |
EA201792287A1 (ru) | Способы лечения рака | |
EA201691896A1 (ru) | Соединения и способы их применения | |
WO2019036417A3 (en) | Inhibition of ngly1 for the treatment of cancer | |
EA201892376A1 (ru) | Комбинированный состав трех противовирусных соединений | |
EA202190766A1 (ru) | Иммуномодуляторы, их композиции и способы применения |